MCM7 and adenocarcinoma: For MCM7, neither high (mean, 35.8 months) nor low (mean, 43.9 months) expression levels in the adenocarcinoma group and neither high (mean, 31.5 months) nor low (mean, 65.2 months) expression levels in the squamous cell carcinoma group demonstrated significant difference in overall survival.